Penghui Zhou Selected Research

Penghui Zhou Research Topics

Disease

31	Neoplasms (Cancer) 01/2024 - 12/2008
5	Melanoma (Melanoma, Malignant) 01/2023 - 03/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2020
3	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2009
3	Microsatellite Instability 01/2021 - 01/2020
3	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 02/2009
1	Autoimmune Diseases (Autoimmune Disease) 12/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2022
1	Lung Neoplasms (Lung Cancer) 11/2022
1	Nausea 01/2022
1	COVID-19 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Carcinogenesis 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Methemoglobinemia 01/2020
1	Rhabdomyosarcoma 01/2020
1	Bites and Stings (Sting) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Atherosclerosis 03/2016
1	Glioma (Gliomas) 01/2015
1	Dyslipidemias (Dyslipidemia) 03/2014
1	Experimental Melanoma 03/2014
1	Adenocarcinoma 10/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2009

Drug/Important Bio-Agent (IBA)

7	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2018
5	AntigensIBA 11/2022 - 10/2009
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 02/2009
3	AntibodiesIBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	InterferonsIBA 11/2022 - 01/2020
2	CytokinesIBA 11/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
2	Therapeutic UsesIBA 01/2022 - 01/2022
2	LipidsIBA 01/2021 - 03/2014
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 02/2009
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2009
1	LisaftoclaxIBA 12/2023
1	AndrogensIBA 01/2023
1	carfilzomibIBA 11/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	CannabinoidsIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	VaccinesIBA 01/2022
1	Dronabinol (THC)FDA LinkGeneric 01/2022
1	LectinsIBA 01/2021
1	fucoidanIBA 01/2021
1	Calcibiotic Root Canal SealerIBA 01/2021
1	Clotrimazole (Lotrimin)FDA LinkGeneric 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Mevalonic Acid (Mevalonate)IBA 01/2021
1	Diacylglycerol KinaseIBA 01/2021
1	Angiogenesis InhibitorsIBA 01/2021
1	Monomeric GTP-Binding ProteinsIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	IpilimumabIBA 01/2020
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	MutagensIBA 01/2020
1	Single-Chain AntibodiesIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020
1	EnzymesIBA 01/2020
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2020
1	MelatoninIBA 02/2019
1	LuciferasesIBA 02/2019
1	Proto-Oncogene Proteins B-rafIBA 02/2019
1	VemurafenibIBA 02/2019
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2019
1	Epithelial Cell Adhesion MoleculeIBA 02/2019
1	GlucocorticoidsIBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	Topoisomerase II InhibitorsIBA 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	Teniposide (VM 26)FDA Link 01/2019
1	Interferon Type IIBA 01/2019
1	CarcinogensIBA 01/2019
1	avasimibeIBA 03/2016
1	Small Interfering RNA (siRNA)IBA 01/2015
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2014
1	AutoantibodiesIBA 03/2014
1	Lymphotoxin beta ReceptorIBA 10/2009
1	Immunoglobulin G (IgG)IBA 10/2009
1	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2009
1	Tumor Viral Antigens (Large T Antigen)IBA 02/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2008
1	Glycogen Synthase Kinase 3 betaIBA 12/2008

Therapy/Procedure

21	Immunotherapy 01/2024 - 02/2009
14	Therapeutics 12/2022 - 02/2009
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
1	Radiotherapy 01/2017
1	Molecular Targeted Therapy 01/2017